On February 21, 2006 Bayer HealthCare, the National Hemophilia Foundation (NHF), and Andretti Green Racing, Inc. announced the launch of Racing for Hemophilia, the first fundraising program of its kind for the hemophilia community. Racing for Hemophilia will leverage the popularity of the Indy Racing League and the Indianapolis 500® Mile Race to raise money and awareness of bleeding and clotting disorders. All funds raised during the Racing for Hemophilia program will support NHF and its participating local chapters.
Bayer HealthCare is donating its own sponsorship space on the renowned #26 Andretti Green Racing car during the 2006 Indianapolis 500 to NHF. Donors who contribute $1,500 or more to NHF or one of its local chapters, in addition to correctly answering five racing trivia questions, will be eligible to be selected as the primary donor of Racing for Hemophilia. The primary donor will have use of Bayer’s sponsor space on the #26 Andretti Green Racing car, to be driven by Marco Andretti at the 90th Indianapolis 500 on May 28, 2006. The featured primary donor will also receive a VIP trip for two to the race as the guest of NHF and Andretti Green Racing.
“We appreciate Bayer’s generous support of Racing for Hemophilia and its long-standing support of NHF,” said CEO Alan Kinniburgh, PhD. “Racing for Hemophilia is an important fundraising and awareness initiative. It will capture the spirit and excitement of the Indianapolis 500 while raising awareness of bleeding disorders among the general public,” he added.
Terry Tenbrunsel, vice president of sales and marketing at Bayer said, “we are excited to partner with NHF and Andretti Green Racing to raise awareness of hemophilia, and believe it is essential to support programs that educate the public about bleeding disorders.”
For more information about Racing for Hemophilia and to make a contribution, visit www.RacingforHemophilia.com.